Jomkwan Ongarj

Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population

Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj et al. · Vaccines · 2021 · 54 citations · Full text

Regulatory T Cells Decreased during Recovery from Mild COVID-19

Purilap Seepathomnarong, Jomkwan Ongarj, Ratchanon Sophonmanee et al. · Viruses · 2022 · 22 citations · Full text

Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population

Nawamin Pinpathomrat, Porntip Intapiboon, Purilap Seepathomnarong et al. · npj Vaccines · 2022 · 14 citations · Full text

T-Cell Responses Induced by an Intradermal BNT162b2 mRNA Vaccine Booster Following Primary Vaccination with Inactivated SARS-CoV-2 Vaccine

Ratchanon Sophonmanee, Jomkwan Ongarj, Bunya Seeyankem et al. · Vaccines · 2022 · 13 citations · Full text

Vaccination, T-cell Responses Induced, Vaccine Development +14